1-11 of 11
Salma Parvin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Integrating High-Throughput Dynamic BH3 Profiling and Molecular Phenotyping to Identify Therapeutic Vulnerabilities in CLL

Salma Parvin, Binyamin A. Knisbacher, Aditi Aryal, Stacey M. Fernandes, Donna S. Neuberg, Catherine J. Wu, Jennifer R. Brown, Gad Getz, Anthony G. Letai
Journal: Blood
Blood (2022) 140 (Supplement 1): 6983–6984.
https://doi.org/10.1182/blood-2022-169352
Published: 2022
Journal Articles

B Cell-Restricted Depletion of Dnmt3a Activates Notch Signaling and Causes Chronic Lymphocytic Leukemia

Shanye Yin, Anat Biran, Helene Kretzmer, Elisa Ten Hacken, Salma Parvin, Fabienne Lucas, Mohamed Uduman, Catherine Gutierrez, Nathan J Dangle, Leah Billington, Fara Regis, Laura Z. Rassenti, Arman W. Mohammad, Mei Zheng, Elizabeth Witten, Thomas J. Kipps, Jon C. Aster, Andreas Gnirke, Donna S. Neuberg, Anthony G. Letai, Lili Wang, Ruben D. Carrasco, Alexander Meissner, Catherine J. Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 249.
https://doi.org/10.1182/blood-2021-150789
Published: 2021
Journal Articles

Dissecting Richter's Syndrome in a Multiplexed CRISPR-Based Mouse Model Reveals Key Changes in MYC, Interferon and BCR Signaling Underlying Transformation

Elisa Ten Hacken, Shanye Yin, Tomasz Sewastianik, Livius Penter, Neil Ruthen, Michaela Gruber, Erin Michelle Parry, Romain Guieze, Robert A. Redd, Mohamed Uduman, Shuqiang Li, Jackson Southard, Maria Hernandez-Sanchez, Salma Parvin, Fen Zhu, Gabriela Brunsting Hoffmann, Elizabeth Witten, Kenneth J. Livak, Matthew S. Davids, Anthony G. Letai, Donna S. Neuberg, Ruben D. Carrasco, Catherine J. Wu
Journal: Blood
Blood (2021) 138 (Supplement 1): 251.
https://doi.org/10.1182/blood-2021-148614
Published: 2021
Journal Articles

CCR2 Expression Signature Can Classify and Predict Outcome in a Subpopulation of Chronic Lymphocytic Leukemia (CLL) Patients

Salma Parvin, PhD, Aditi Aryal, BA, Matthew S. Davids, MD, Anthony G. Letai, MD PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-141642
Published: 2020
Journal Articles

Leukemia Cell of Origin Influences p53 Activity and Therapeutic Sensitivity Via an Evi1-Dependent Mechanism

Sheng F Cai, MD PhD, S Haihua Chu, PhD, Aaron D Goldberg, MD PhD, Salma Parvin, PhD, Richard Koche, PhD, Jacob L Glass, MD PhD, Eytan M. Stein, MD, Martin S. Tallman, MD, Filiz Sen, MD, Christopher Famulare, MS, Monica Cusan, MD, Chun-Hao Huang, PhD, Chun-Wei David Chen, PhD, Lihua Zou, PhD, Keith B Cordner, BS, Vidushi Durani, MS, Mitali Kini, BS, Madison Rex, Johannes Zuber, Timour Baslan, PhD, Scott W. Lowe, PhD, Hugh Young Rienhoff, Jr., MD, Ross L. Levine, MD, Scott A. Armstrong, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 109.
https://doi.org/10.1182/blood-2019-122483
Published: 2019
Journal Articles

Identification of Genotype-Specific Therapeutic Vulnerabilities By Comparative Dynamic BH3 Profiling Analysis of Human and Murine CLL

Shanye Yin, PhD, Salma Parvin, PhD, Elisa Ten Hacken, PhD, Rebecca Valentin, MD, Heather Joyal, Laura Z. Rassenti, PhD, Emanuela M. Ghia, PhD, Thomas J. Kipps, MD PhD, Donna S Neuberg, ScD, Lili Wang, MD PhD, Matthew S. Davids, MD, Ruben D. Carrasco, MD PhD, Anthony G. Letai, MD PhD, Catherine J. Wu, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4281.
https://doi.org/10.1182/blood-2019-127293
Published: 2019
Journal Articles

LMO2 Facilitates Synthetic Lethality after PARP Inhibition (PARPi) in Diffuse Large B-Cell Lymphoma (DLBCL)

Ramiro E Verdun, PhD, Salma Parvin, PhD, Ariel Ramirez Labrada, PhD, Gabriel Emmanuel Santiago, Cortizas M Elena, Sharabi Eden, Aumann Shlomzion, MD, Zhang Yu, PhD, Isidro Sanchez-Garcia, PhD, Francisco Vega, MD PhD, Jennifer Rose Chapman-Fredricks, MD, Izidore S. Lossos, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 674.
https://doi.org/10.1182/blood-2018-99-110825
Published: 2018
Journal Articles

Anti-CD20-interleukin-21 fusokine targets malignant B cells via direct apoptosis and NK-cell–dependent cytotoxicity

Shruti Bhatt, Salma Parvin, Yu Zhang, Hyun-Mi Cho, Kranthi Kunkalla, Francisco Vega, John M. Timmerman, Seung-Uon Shin, Joseph D. Rosenblatt, Izidore S. Lossos
Journal: Blood
Blood (2017) 129 (16): 2246–2256.
https://doi.org/10.1182/blood-2016-09-738211
Published: 2017
Includes: Supplemental data
Journal Articles

Novel Role of LMO2 in DNA Repair Control in Diffuse Large B Cell Lymphoma

Salma Parvin, Ariel Ramirez Labrada, PhD, Gabriel E. Santiago, Elena M. Cortizas, Elena Cubedo Gil, PhD, Ramiro E Verdun, PhD, Izidore S Lossos, MD
Journal: Blood
Blood (2016) 128 (22): 776.
https://doi.org/10.1182/blood.V128.22.776.776
Published: 2016
Journal Articles

Direct and immune-mediated cytotoxicity of interleukin-21 contributes to antitumor effects in mantle cell lymphoma

Shruti Bhatt, Julie Matthews, Salma Parvin, Kristopher A. Sarosiek, Dekuang Zhao, Xiaoyu Jiang, Elif Isik, Anthony Letai, Izidore S. Lossos
Journal: Blood
Blood (2015) 126 (13): 1555–1564.
https://doi.org/10.1182/blood-2015-01-624585
Published: 2015
Includes: Supplemental data
Journal Articles

Interleukin-21 Potently Induces Direct and Indirect Cytotoxicity of Mantle Cell Lymphoma

Shruti Bhatt, PhD, Kristopher Sarosiek, PhD, Salma Parvin, Julie Marie Matthews, PhD, Dekuang Zhao, PhD, Izidore S. Lossos, MD
Journal: Blood
Blood (2014) 124 (21): 1776.
https://doi.org/10.1182/blood.V124.21.1776.1776
Published: 2014